User menu

Well-differentiated pancreatic tumor/carcinoma: insulinoma.

Bibliographic reference de Herder, Wouter W ; Niederle, Bruno ; Scoazec, Jean-Yves ; Pauwels, Stanislas ; Kloppel, Gunter ; et. al. Well-differentiated pancreatic tumor/carcinoma: insulinoma.. In: Neuroendocrinology, Vol. 84, no. 3, p. 183-8 (2006)
Permanent URL http://hdl.handle.net/2078.1/28299
  1. Grant CS: Insulinoma. Best Pract Res Clin Gastroenterol, 19, 783 (2005)
  2. Herder WW: Insulinoma. Neuroendocrinology, 80, 20 (2004)
  3. Rindi G, Neuroendocrinology, 80, 12 (2004)
  4. John Service F., Insulinoma and other islet-cell tumors, Cancer Treatment and Research (1997) ISBN:9781461379195 p.335-346, 10.1007/978-1-4615-6355-6_15
  5. Service F.J., Hypoglycemic Disorders, 10.1056/nejm199504273321707
  6. Service FJ, J Clin Endocrinol Metab, 84, 1582 (1999)
  7. Service FJ, J Clin Endocrinol Metab, 85, 3973 (2000)
  8. Service FJ, Mayo Clin Proc, 51, 417 (1976)
  9. Anlauf M, Am J Surg Pathol, 29, 524 (2005)
  10. Noone TC, Best Pract Res Clin Endocrinol Metab, 19, 195 (2005)
  11. Gouya Hervé, Vignaux Olivier, Augui Joelle, Dousset Bertrand, Palazzo Laurent, Louvel André, Chaussade Stanislas, Legmann Paul, CT, Endoscopic Sonography, and a Combined Protocol for Preoperative Evaluation of Pancreatic Insulinomas, 10.2214/ajr.181.4.1810987
  12. Semelka RC, J Magn Reson Imaging, 11, 141 (2000)
  13. Pamuklar E, Magn Reson Imaging Clin N Am, 13, 313 (2005)
  14. Thoeni Ruedi F., Mueller-Lisse Ullrich G., Chan Ronald, Do Nam Ky, Shyn Paul B., Detection of Small, Functional Islet Cell Tumors in the Pancreas: Selection of MR Imaging Sequences for Optimal Sensitivity, 10.1148/radiology.214.2.r00fe32483
  15. Owen N J, Sohaib S A A, Peppercorn P D, Monson J P, Grossman A B, Besser G M, Reznek R H, MRI of pancreatic neuroendocrine tumours, 10.1259/bjr.74.886.740968
  16. Catalano C, Acta Radiol, 40, 644 (1999)
  17. Kann PH, Exp Clin Endocrinol Diabetes, 113, 471 (2005)
  18. McLean AM, Best Pract Res Clin Endocrinol Metab, 19, 177 (2005)
  19. Jackson JE, Best Pract Res Clin Endocrinol Metab, 19, 229 (2005)
  20. Hiramoto JS, Arch Surg, 136, 1020 (2001)
  21. Norton JA, Ann Oncol, 10, 182 (1999)
  22. Grover AC, Surgery, 138, 1003 (2005)
  23. Berends FJ, Surgery, 128, 386 (2000)
  24. Vezzosi D, Eur J Endocrinol, 152, 757 (2005)
  25. Krenning E. P., Kwekkeboom D. J., Bakker W. H., Breeman W. A. P., Kooij P. P. M., Oei H. Y., van Hagen M., Postema P. T. E., de Jong M., Reubi J. C., Visser T. J., Reijs A. E. M., Hofland L. J., Koper J. W., Lamberts S. W. J., Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients, 10.1007/bf00181765
  26. Bertherat J., Tenenbaum F., Perlemoine K., Videau C., Alberini J. L., Richard B., Dousset B., Bertagna X., Epelbaum J., Somatostatin Receptors 2 and 5 Are the Major Somatostatin Receptors in Insulinomas: Anin Vivoandin VitroStudy, 10.1210/jc.2002-021895
  27. Orlefors H., Sundin A., Garske U., Juhlin C., Oberg K., Skogseid B., Langstrom B., Bergstrom M., Eriksson B., Whole-Body11C-5-Hydroxytryptophan Positron Emission Tomography as a Universal Imaging Technique for Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and Computed Tomography, 10.1210/jc.2004-1938
  28. Eriksson B, Best Pract Res Clin Endocrinol Metab, 19, 311 (2005)
  29. Aranha GV, Am J Surg, 189, 223 (2005)
  30. Kaczirek K, Wien Klin Wochenschr, 117, 19 (2005)
  31. Stabile BE, Gastroenterologist, 5, 213 (1997)
  32. Stehouwer CD, Neth J Med, 35, 86 (1989)
  33. Cohen MS, Lancet, 40 (1973)
  34. Brodows RG, J Clin Endocrinol Metab, 38, 159 (1974)
  35. Lamberts Steven W.J., van der Lely Aart-Jan, de Herder Wouter W., Hofland Leo J., Octreotide, 10.1056/nejm199601253340408
  36. Stehouwer CD, Acta Endocrinol (Copenh), 121, 34 (1989)
  37. Eriksson B, Lancet, 1307 (1986)
  38. Danforth, Surgery, 96, 1027 (1984)
  39. Kwekkeboom Dik J., Teunissen Jaap J., Bakker Willem H., Kooij Peter P., de Herder Wouter W., Feelders Richard A., van Eijck Casper H., Esser Jan-Paul, Kam Boen L., Krenning Eric P., Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors, 10.1200/jco.2005.08.066
  40. O'Toole D, Endocr Relat Cancer, 10, 463 (2003)
  41. Rougier P, Digestion, 62, 73 (2000)